OHSU in the news

AstraZeneca approval in U.K. 'good sign' for the U.S.

KPTV December 30, 2020
In a story about the UK’s approval of AstraZeneca’s vaccine, Marcel Curlin, M.D., says, “Before it becomes available to the public (in the U.S.), it’s going to go through the FDA process, which is an independent and separate review process. … But coming in with that background of it having already been approved in the U.K. is just good news.”

2020: Not bad business!

Portland Business Tribune December 29, 2020
In a Portland Business Tribune article on how businesses were affected in 2020, Tom Beer, M.D., says “We've all had to adjust as we navigate the changing COVID-19 landscape, and the team at the Knight Cancer Institute was able to continue to offer cutting-edge clinical trial and treatment options for our patients who need it most."

Multiple myeloma: Choosing your path

Cancer Today December 28, 2020
Rebecca Silbermann, M.D., discusses the possibility of relapse for patients with multiple myeloma. She says, “We hope that they don’t [relapse] for a really long time, but the expectation is that this will be a chronic disease that will have to be managed over a patient’s lifetime.”

What you need to know about getting tested for coronavirus

The New York Times December 28, 2020
Esther Choo, M.D., says getting a test result should stop COVID-positive people from gathering with others, but adds “Testing negative basically changes nothing about behavior. It still means wear a mask, distance, avoid indoors if you can.”

Holidays and COVID: Mid-January before any surge is known

KOIN-TV December 28, 2020
David Zonies, M.D., discusses high hospitalization rates and COVID fatigue. “I have to urge people to hang in there for this New Year’s holiday ahead. The pull to be inside with friends and family, with vaccine coming online with the new year, my sense is we are at the three-quarter mark of this marathon.”
See more stories